A novel Mycobacterium tuberculosis-specific subunit vaccine provides synergistic immunity upon co-administration with Bacillus Calmette-Guerin
J. S. Woodworth, H. Strand Clemmensen, H. Battey, K. Dijkman, T. Lindenstrom, R. Salvador Laureano, R. Taplitz, J. Morgan, C. Aagaard, I. Rosenkrands, C. S. Lindestam Arlehamn, P. Andersen, R. Mortensen
This study develops a Mycobacterium tuberculosis-specific subunit vaccine, H107, which when co-administered with BCG enhances immune responses and provides better protection than either vaccine alone.
bioRxiv · Mar 18, 2021Immunology